Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Current Vascular Pharmacology|May 30, 2013
Clinical Uses of 1,25-dihydroxy-19-nor-vitamin D(2) (Paricalcitol)J Bover, I Dasilva, M Furlano, et al.
Contributions to Nephrology|June 2, 2012
Role of vitamin D receptor activators in peritoneal dialysisJ Bover, M J Lloret, I DaSilva, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|November 20, 2008
[Unawareness of the K/DOQI guidelines for bone and mineral metabolism in predialysis chronic kidney disease: results of the OSERCE Spanish multicenter-study survey]J Bover, J L Górriz, A L Martín de Francisco, et al.
Kidney International|April 1, 1994
Factors in the development of secondary hyperparathyroidism during graded renal failure in the ratJ Bover, M Rodriguez, P Trinidad, et al.
Annals of Clinical Biochemistry|November 21, 1997
Changes in serum osteocalcin levels in the follow-up of kidney transplantationM R Bonnin, M T Gonzalez, J M Griñó, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Cyclosporin A (CsA) and azathioprine (AZA) combination in renal allografts with CsA nephrotoxicityA M Castelao, J M Griño, I Sabate, et al.
EDTNA/ERCA Journal (English Ed.)|September 10, 2002
A practical approach to the molecular biology of kidney diseases: from basic science to bed sideP Garrido, E Vélez, A Izquierdo, et al.
Presse Medicale (Paris, France : 1983)|November 27, 1991
[Antilymphocyte serum, cyclosporine and corticoids, versus OKT3, cyclosporine, and corticoids in kidney transplantation]J M Grino, A M Castelao, D Seron, et al.
Pageof 4